Search research articles
Contact Us
Filters
Showing results (71-80 of 133) with videos related to
Page
of 14
Sort By:
Frontiers in Pharmacology
|
January 8, 2024
A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database
Fan Zou, Chengyu Zhu, Siyu Lou, et al.
Aging
|
September 5, 2020
PTEN participates in airway remodeling of asthma by regulating CD38/Ca<sup>2+</sup>/CREB signaling
Yuanyuan Wu, Yiyi Lu, Fan Zou, et al.
Oncology Reports
|
July 14, 2015
Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway
Xiaolong Yu, Xin Zhou, Changlin Fu, et al.
Journal of Virology
|
August 19, 2016
Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy
Bingfeng Liu, Fan Zou, Lijuan Lu, et al.
BMC Psychiatry
|
January 20, 2025
A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databases
Siyu Lou, Zhiwei Cui, Yingyong Ou, et al.
Frontiers in Pharmacology
|
November 13, 2023
A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?
Zhiwei Cui, Feiyan Cheng, Lihui Wang, et al.
World Journal of Surgical Oncology
|
September 27, 2023
Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy
Zhiwei Cui, Fan Zou, Rongli Wang, et al.
Frontiers in Pharmacology
|
March 27, 2025
Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting system
Chengyu Zhu, Zhiwei Cui, Tingting Liu, et al.
Journal of Translational Medicine
|
August 28, 2025
Construction of lactylation (LA) risk signature in prostate cancer based on 4D fast DIA L-lactated quantitative genomics
Fan Zou, Yongchen Jin, Ziteng Zhang, et al.
Oncology Letters
|
October 16, 2019
Screening and authentication of molecular markers in malignant glioblastoma based on gene expression profiles
Yang-Fan Zou, Ling-Bing Meng, Zhao-Kai He, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 133) with videos related to
Sort By:
Page
of 14
Frontiers in Pharmacology
|
January 8, 2024
A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database
Fan Zou, Chengyu Zhu, Siyu Lou, et al.
Aging
|
September 5, 2020
PTEN participates in airway remodeling of asthma by regulating CD38/Ca<sup>2+</sup>/CREB signaling
Yuanyuan Wu, Yiyi Lu, Fan Zou, et al.
Oncology Reports
|
July 14, 2015
Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway
Xiaolong Yu, Xin Zhou, Changlin Fu, et al.
Journal of Virology
|
August 19, 2016
Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy
Bingfeng Liu, Fan Zou, Lijuan Lu, et al.
BMC Psychiatry
|
January 20, 2025
A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databases
Siyu Lou, Zhiwei Cui, Yingyong Ou, et al.
Frontiers in Pharmacology
|
November 13, 2023
A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?
Zhiwei Cui, Feiyan Cheng, Lihui Wang, et al.
World Journal of Surgical Oncology
|
September 27, 2023
Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy
Zhiwei Cui, Fan Zou, Rongli Wang, et al.
Frontiers in Pharmacology
|
March 27, 2025
Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting system
Chengyu Zhu, Zhiwei Cui, Tingting Liu, et al.
Journal of Translational Medicine
|
August 28, 2025
Construction of lactylation (LA) risk signature in prostate cancer based on 4D fast DIA L-lactated quantitative genomics
Fan Zou, Yongchen Jin, Ziteng Zhang, et al.
Oncology Letters
|
October 16, 2019
Screening and authentication of molecular markers in malignant glioblastoma based on gene expression profiles
Yang-Fan Zou, Ling-Bing Meng, Zhao-Kai He, et al.
Page
of 14